1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial . Lancet. 2003;361(9358):662-668.

Publication Type:

Journal Article

Authors:

Kakko, J; Svanborg, KD; Kreek, MJ; Heilig, M

Source:

Lancet, Volume 361, Issue 9358, p.662-668 (2003)

Cited On:

Key Populations: Identification and Management of HCV in People Who Inject Drugs

Export Citation:

RIS Format

Top